2019 Cardiovascular Medicine and Prevention Update for Primary Care

Middleton, WI US
April 12, 2019

Practice Gaps and Needs

Cardiovascular medicine is a vast area of clinical practice with a continually rapid expansion of knowledge, guidelines, best practices and new technology. Primary care clinicians are challenged to optimally manage a multitude of diseases involving the cardiovascular system including the failing heart, the heart with abnormal arrhythmias and the circulation affected by abnormal cholesterol metabolism and hypertension. Several national guidelines that help clinicians establish best practices have been modified and refined in the last year. The implications of these new guidelines and their utilization will be a major topic of discussion in this symposium.

There is an ongoing evolution of care for patients with ventricular dysfunction. Another segment of the symposium will focus on several aspects of treating patients with ventricular dysfunction. A frequently overlooked area of treatment is the pulmonary hypertension that ventricular dysfunction produces and how to manage it. In addition, the rapidly emerging area of cardio-oncology which seeks to treat and prevent cardiac dysfunction from chemotherapeutic agents is an emerging area of importance. Practice management, particularly of patients with heart failure with preserved ejection fraction, a particular problem of the elderly, will be addressed.

Cardiac arrhythmias remain a source of continued evolution as technology evolves, now to the point that patients may be wearing their own devices that detect arrhythmias. A segment on arrhythmias will address this issue discussing how to manage these patients when they bring their own data. Additional modifications of the atrial fibrillation guidelines are expected to be available by the time of the symposium, with particular emphasis on utilization of anticoagulation agents. These new results, which fulfill another practice gap in our knowledge about treating patients with atrial fibrillation, will be discussed, along with the interpretation of the multitude of different types of ambulatory monitoring devices.

Several practice related topics continue to perplex and challenge primary care providers.  One area is that of complementary medicine.  How do these self-administered medications fit into the entire plan of patient care? Can they be harmful to the heart? Additionally, the perplexing problem of continual focus on diets present constant problems for primary care providers. Several other topics of increasing importance present in primary care practices: the congenital heart disease patient seeking ongoing care, the geriatric patient with persistent hypertension and the ongoing debate of where aspirin fits in in primary prevention will topics of discussion in the breakout sessions.

Intended Audience

This activity is designed for physicians, nurse practitioners, physician assistants, pharmacists, nurses and other allied health personnel working in the field of primary care who treat and evaluate patients in need of prevention and treatment of cardiovascular diseases.

Elements of Competence

This CE activity has been designed to improve learner competence and focuses on the American Board of Medical Specialties' areas of patient care and procedural skills, and medical knowledge.

This activity also focuses on the Interprofessional competencies of roles/responsibilities, interprofessional communication, and teams/teamwork.

Learning Objectives

At the conclusion of the activity, the healthcare team will be able to:

  1. Identify best practices for the treatment of hypertension both in the elderly and across the entire age spectrum.
  2. Review new guidelines and identify best practices for anticoagulation of patients with atrial arrhythmias.
  3. Discuss the implications of patient initiated activities such as self-monitoring for arrhythmias, self-directed diets and self-directed use of nontraditional complementary medications and therapies.
  4. Describe the implications of the new guidelomes for treatment of cholesterold and various lipid abnormalities.
  5. Review new and evolving information on the role of aspirin in primary prevention.
  6. Explain the results and implications of data produced by various types of ambulatory monitoring devices.
  7. Distinguish the new areas of management of patients with heart failure who have pulmonary hypertension secondary to their underlying LV dysfunction, left ventricular and right ventricular dysfunction secondary to chemotherapeutic therapies for cancer and patients who have classic symptoms of heart failure despite having a normal ejection fracture.

Additional Information

Course summary
Available credit: 
  • 7.00 ACPE Contact Hours - Pharmacist
  • 7.00 AMA PRA Category 1 Credit
  • 7.00 ANCC Contact Hours
  • 7.00 CDR CPEUs
  • 7.00 Iowa Board of Nursing Contact Hours
  • 7.00 University of Wisconsin–Madison Continuing Education Hours
Registration opens: 
11/01/2018
Course expires: 
12/31/2019
Event starts: 
04/12/2019 - 7:00am CDT
Event ends: 
04/12/2019 - 5:00pm CDT
Cost:
$295.00
Rating: 
0

Friday, April 12, 2019        


 

AM PM 
6:30Doors Open for Exhibit Set-up12:20Session III: Heart Failure
7:00Registration/Breakfast with Exhibitors Moderator: Peter Rahko, MD
7:55Welcome and Intro12:25Dyspnea Evaluation: Diagnostic Path Leading to Pulmonary Hypertension
 Peter Rahko, MD Farhan Raza, MD
8:00Session I: Prevention12:50Cardio-Oncology Pearls
 Moderator: Matthew Tattersall, DO, MS Steven Ewer, MD
8:05The 2018 Cholesterol Guidelines: New Again?1:15My Patient with HFpEF: What Options Do I Have?
 James Stein, MD David Pham, MD
8:30Taking a Dive: Is 130 the New 140 for Hypertension?1:40Practical Office-Based Management of Heart FailurePractical Office-Based Management of Heart FailurePractical Office-Based Management of Heart Failure
 Heather Johnson, MD, MS Joan Hermsen, APNP
8:55How Integrative Medicine Approaches Can Help Prevent Heart Disease2:05Panel Discussion
 Renee Bobb, APNP Session III Moderator & Presenters
9:20Panel Discussion2:35Break with Exhibitors
 Session I Moderator & Presenters2:50Session IV: Arrhythmia
9:50Intro to Breakout Sessions Moderator: Miguel Leal, MD
 Peter Rahko, MD2:55My Watch Tells Me the Time...To See a Cardiologist!
9:55Break with Exhibitors Zachary Goldberger, MD
 

Session II: Breakouts
Choose 2 of the following:

  1. Recognizing Fact, Fiction and FAD - How to Help Your Patients Make Heart Healthy Eating Choices
    Kavitha Poddar, PhD, RD, CD
  2. You Had What Surgery as a Child? Treating Adults With Congenital Heart Disease
    Heather Bartlett, MD
  3. I'm Too Old for This! Safely Controlling Blood Pressure in Older Patients
    Adam Gepner, MD
  4. Aspirin in Primary Prevention: Barking up the Wrong Tree?
    Karen Kopacek, MS, RPh
3:25Interpreting Ambulatory ECG Monitoring
 Ryan Kipp, MD
3:55Afib Guidelines Update Including NOACs
 Craig January, MD, PhD & Kathy Wackerle, APNP
4:25Panel Discussion
 Session IV Moderator & Presenters
4:55Summary
 Peter Rahko, MD
5:00Adjourn
10:10Breakout Session  
10:40Intermission  
10:50Breakout Session  
11:20Lunch with Exhibitors  

                     

     

               

Madison Marriott West
1313 John Q Hammons Drive
Middleton, WI 53562
United States
+1 (888) 745-2032

Conference Housing

A block of rooms has been reserved at the conference site, the Madison Marriott West. Please call the hotel directly (888.745.2032) to arrange accommodations. To receive the special rate of $149 (plus tax) for a single or double, please mention the UW Cardio 2019 group when making your reservation. The block of rooms will be held on a first-come, first-serve basis and any available rooms that have not been reserved by 5 PM CST on March 11, 2019 will be released to the general public. The hotel charges $8.00 per vehicle per night for overnight guests.

Your online reservation link is:  Book your group rate for UW Cardio 2019

Conference Attire

Casual attire is appropriate for this conference. Since meeting room temperatures and personal comfort levels vary, it is recommended that you bring a sweater or jacket to the educational activity.

COURSE DIRECTORS

*Peter Rahko, MD, Professor of Medicine, Cardiovascular Medicine Division, UW SMPH; Director, Adult Echocardiography Laboratory

*James Stein, MD, Robert Turell Professor in Cardiovascular Research, Cardiovascular Medicine Division, UW SMPH; Director, Atherosclerosis Imaging Research Program; Director, Preventive Cardiology Program

PRESENTERS, MODERATORS & PLANNERS

*Terese Bailey, BS, Senior Outreach Specialist, Office of Continuing Professional Development in Medicine and Public Health, UW SMPH

*Ashley Bartlett, BS, Administrative Program Specialist, Cardiovascular Medicine Division, UW SMPH

Heather Bartlett, MD, Associate Professor of Pediatrics and Medicine (CHS), Pediatric Cardiology, UW SMPH; Director, Adult Congenital Heart Disease Program

*Mark Beamsley, MD, Clinical Associate Professor of Medicine, Department of Family Medicine and Community Health, UW SMPH

*Kate Berry, Medical Program Assistant, Senior – Division Scheduler, Cardiovascular Medicine Division, UW SMPH

Renee Bobb, APNP, Cardiovascular Medicine Division, UW SMPH

Steven Ewer, MD, Associate Professor of Medicine (CHS), Cardiovascular Medicine Division, UW SMPH

*Adam Gepner, MD, Cardiologist, William S. Middleton Memorial Veterans Hospital; Clinical Adjunct Assistant Professor of Medicine, Cardiovascular Medicine Division, UW SMPH

Zachary Goldberger, MD, Associate Professor of Medicine (CHS), Cardiovascular Medicine Division, UW SMPH

*Todd Goldman, MD, Clinical Assistant Professor of Medicine, Cardiovascular Medicine Division, UW SMPH; Director of Adult Echocardiography, William S. Middleton Memorial Veterans Hospital

*Joan Hermsen, APNP, UW Heart Failure/Transplant, Cardiovascular Medicine Division, UW SMPH; APP Supervisor, Cardiology

*Kurt Jacobson, MD, MHSA, Assistant Professor of Medicine (CHS), Section of Coronary, Vascular, and Structural Heart Interventions, Divisions of Cardiovascular and Internal Medicine, UW SMPH and American Family Children’s Hospital; Program Director, Interventional Cardiology Fellowship Program

*Craig January, MD, PhD, Professor of Medicine, Cardiovascular Medicine Division, UW SMPH; Director, Heart Station

Heather M. Johnson, MD, MS, Associate Professor of Medicine, Cardiovascular Medicine Division, UW SMPH; Co-Director, UW Health Advanced Hypertension Program

*Maryl Johnson, MD, Professor of Medicine (CHS), Heart Failure and Transplant Cardiology, Cardiovascular Medicine Division, UW SMPH

Ryan Kipp, MD, Assistant Professor of Medicine (CHS), Cardiovascular Medicine Division, UW SMPH

*Karen Kopacek, MS, RPh, Associate Professor (CHS), Associate Dean for Student and Alumni Affairs, UW-Madison School of Pharmacy

*Miguel Leal, MD, Assistant Professor of Medicine (CHS), Cardiovascular Medicine Division, UW SMPH; Program Director, Cardiovascular Medicine & Clinical Cardiac Electrophysiology Fellowship Programs; Director, UW Device Clinic & Lead Management Program

David Pham, MD, Clinical Assistant Professor of Medicine, Cardiovascular Medicine Division, UW SMPH

Kavita Poddar, PhD, RD, CD, Clinical Nutritionist, UWHC

Farhan Raza, MD, Assistant Professor of Medicine (CHS), Cardiovascular Medicine Division, UW SMPH

*Charles Stone, MD, Associate Professor of Medicine and Radiology, Cardiovascular Medicine Division, UW SMPH; Director, UW Health Nuclear Cardiology, Director, UW Health Regional Services

Matthew Tattersall, DO, MS, Assistant Professor of medicine (CHS), Cardiovascular Medicine, UW SMPH

Kathy Wackerle, APNP, Cardiovascular Medicine Division, UW SMPH

*Kathleen Walsh, DO, Clinical Associate Professor of Medicine, Cardiovascular Medicine and Geriatrics Divisions, UW SMPH; Associate Director, UW Faint and Fall Clinic

*Denise Zang, MBA, FACMPE, Division Administrator, Cardiovascular Medicine Division, UW SMPH

*= Planning Committee Member

POLICY ON DISCLOSURE

It is the policy of the University of Wisconsin–Madison ICEP that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s).

Name

Role

Financial Relationship Disclosures

Discussion of Unlabeled/

Unapproved uses of drugs/devices in presentation?

*Terese BaileyPlannerNo Relevant Financial Relationships to DiscloseNo
*Ashley BartlettPlannerNo Relevant Financial Relationships to DiscloseNo
Heather Bartlett, MDPresenterNo Relevant Financial Relationships to DiscloseNo
Mark Beamsley, MDPlannerNo Relevant Financial Relationships to DiscloseNo
*Kate BerryPlannerNo Relevant Financial Relationships to DiscloseNo
Renee Bobb, APNPPresenterNo Relevant Financial Relationships to DiscloseNo
Steven Ewer, MDPresenterNo Relevant Financial Relationships to DiscloseNo
*Adam Gepner, MDPlanner & PresenterNo Relevant Financial Relationships to DiscloseNo
Zachary Goldberger, MDPresenterNo Relevant Financial Relationships to DiscloseNo
*Todd Goldman, MDPlannerNo Relevant Financial Relationships to DiscloseNo
*Joan Hermsen, APNPPlanner & PresenterNo Relevant Financial Relationships to DiscloseYes
*Kurt Jacobson, MD, MHSAPlannerMedtronic (Consultant)No
*Craig January, MD, PhDPlanner & PresenterNo Relevant Financial Relationships to DiscloseNo
Heather Johnson, MD, MSPresenterEisai/Pfizer (Co-Investigator)No
*Maryl Johnson, MDPlannerCVS Pharmacy (Consultant); Medtronic (DSMB Chair for Circulatory Support Devices Studies); Optum (Member of Advisory Committee or Review Panel); General Electric (Member of Steering Committee for a Clinical Trial)No
Ryan Kipp, MDPresenterNo Relevant Financial Relationships to DiscloseNo
*Karen Kopacek, MS, RPhPlanner & PresenterNo Relevant Financial Relationships to DiscloseNo
*Miguel Leal, MDPlanner & ModeratorNo Relevant Financial Relationships to DiscloseYes
David Pham, MDPresenterNo Relevant Financial Relationships to DiscloseNo
Kavita Poddar, PhD, RD, CDPresenterNo Relevant Financial Relationships to DiscloseNo
*Peter Rahko, MDPlanner & ModeratorAmgen, Merck (PI)No
Farhan Raza, MDPresenterNo Relevant Financial Relationships to DiscloseNo
*James Stein, MDPlanner & PresenterUp-to-date, Inc. (Author of Chapter); Eli Lilly & Company (Data Safety Monitoring Board); WARF (Inventor)No
*Charles Stone, MDPlannerNo Relevant Financial Relationships to DiscloseNo
Matthew Tattersall, DO, MSModeratorNo Relevant Financial Relationships to DiscloseNo
Kathy Wackerle, APNPPresenterNo Relevant Financial Relationships to DiscloseNo
*Kathleen Walsh, DOPlannerNo Relevant Financial Relationships to DiscloseNo
*Denise Zang, MBA, FACMPEPlannerNo Relevant Financial Relationships to DiscloseNo

* The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.

Discloser List CME Internal Report

Accreditation Statement

Jointly Accredited Provider LogoIn support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


 

 

 

 

 

 

Credit Designation Statements

Accreditation Council of Pharmacy Education (ACPE)

A maximum of 7.00 hours of knowledge-based CE credit can be earned by successfully completing this live activity. Pharmacists should claim only the credit commensurate with the extent of their participation in the activity. CE credit information, based on verification of live attendance and completion of the program assessment and evaluation, will be provided to NABP within 60 days after the activity completion.

Universal Activity Number (UAN) JA0000358-0000-19-012-L01-P, 7.0 hours (0.70 CEUs)

American Medical Association (AMA)

The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 7.0 AMA PRA Category 1 CreditsPhysicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC) & Iowa Board of Nursing

The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 7.0 ANCC and Iowa contact hours (2.25 of which are eligible for pharmacotherapeutic contact hours).

The University of Wisconsin–Madison School of Nursing is Iowa Board of Nursing provider 350. A copy of the evaluation(s) may be sent to the Iowa Board of Nursing, 400 SW 8th St., Ste B, Des Moines, IA 50309.

Continuing Education Units (CEUs)

The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for .70 continuing education units (CEUs) or 7.0 hours. 

American Academy of Family Physicians (AAFP)

This Live activity, Cardiovascular Medicine and Prevention Update for Primary Care, with a beginning date of 04/12/2019, has been reviewed and is acceptable for up to 7.00 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Academy of Nutrition and Dietetics

This activity has been approved by the Commission on Dietetic Registration for 7 CPEUs.

Available Credit

  • 7.00 ACPE Contact Hours - Pharmacist
  • 7.00 AMA PRA Category 1 Credit
  • 7.00 ANCC Contact Hours
  • 7.00 CDR CPEUs
  • 7.00 Iowa Board of Nursing Contact Hours
  • 7.00 University of Wisconsin–Madison Continuing Education Hours

Cost:
$295.00
Please login or register to take this course.

REGISTRATION DEADLINE: April 10, 2019

The conference fee includes the cost of tuition, breakfast, lunch, refreshment breaks, and a nonrefundable processing fee of $25.

CANCELLATION AND REFUND POLICY

Requests for cancellation must be submitted in writing to help@icep.wisc.edu. Cancellation requests received at least 96 hours (April 8) prior to the conference will allow a full refund except for the $25 nonrefundable processing fee. No refunds will be made for cancellations received less than 96 hours prior to the activity start date.

QUESTIONS ABOUT REGISTRATION

Email help@icep.wisc.edu or call 608-262-7226

PROGRAM CHANGES

Emergency situations occasionally occur and may necessitate topic or speaker changes. The University of Wisconsin School of Medicine and Public Health and the University of Wisconsin–Madison ICEP reserve the right to alter or substitute a topic or speaker without prior notification.

FOR FURTHER INFORMATION

For conference information or details regarding exhibit booths please contact Ashley Bartlett at 608.263.9473 or abartlett@medicine.wisc.edu